Article Text

PDF

HLA types in patients with rheumatoid arthritis developing leucopenia after both gold and sulphasalazine treatment.
  1. H Bliddal,
  2. B Eiberg,
  3. P Helin,
  4. A Svejgaard
  1. Department of Rheumatology, Bispebjerg Hospital, Copenhagen, Denmark.

    Abstract

    HLA types, especially HLA-DR3, are associated with the development of toxic reactions in patients with rheumatoid arthritis after treatment with gold or D-penicillamine. In this study, after treatment with sulphasalazine, leucopenia was observed in three patients, who all had a history of leucopenia after previous gold treatment. The HLA types of these patients did not include HLA-DR3; the two patients developing mild leucopenia had HLA-DR2 and the one developing agranulocytosis had HLA-DR4.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Linked Articles